Gene dosage effect for beta-glucuronidase (GUSB) in monosomy 7 cells of patients with myeloproliferative disorders.

C. Danesino, F. Pasquali

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The demonstration of a gene dosage effect in a neoplastic cell with a specific chromosome abnormality could be helpful in the study of some pathogenetic steps of the malignant growth. We tested the activities of beta-glucuronidase (GUSB), whose gene is mapped on chromosome 7 and of Arylsulphatase A (ARSA) and beta-galactosidase (GLB) as control lysosomal enzymes, whose loci are not assigned to number 7, in a group of 10 patients with myeloproliferative disorders associated with monosomy 7. A significant difference of the levels of activity of GUSB in monosomy 7 cells was found in comparison with two groups of controls, one of healthy subjects, the other of patients with similar disorders without monosomy 7. These results indicate the presence of a gene dosage effect for GUSB.

Original languageEnglish
Pages (from-to)133-142
Number of pages10
JournalActa anthropogenetica
Volume7
Issue number2
Publication statusPublished - 1983

Fingerprint

Myeloproliferative Disorders
Gene Dosage
Glucuronidase
Cerebroside-Sulfatase
Chromosomes, Human, Pair 7
beta-Galactosidase
Chromosome Aberrations
Healthy Volunteers
Control Groups
Enzymes
Growth
Genes
Monosomy Chromosome 7

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gene dosage effect for beta-glucuronidase (GUSB) in monosomy 7 cells of patients with myeloproliferative disorders. / Danesino, C.; Pasquali, F.

In: Acta anthropogenetica, Vol. 7, No. 2, 1983, p. 133-142.

Research output: Contribution to journalArticle

@article{e42f758901e14fa4ba87b60312825c6d,
title = "Gene dosage effect for beta-glucuronidase (GUSB) in monosomy 7 cells of patients with myeloproliferative disorders.",
abstract = "The demonstration of a gene dosage effect in a neoplastic cell with a specific chromosome abnormality could be helpful in the study of some pathogenetic steps of the malignant growth. We tested the activities of beta-glucuronidase (GUSB), whose gene is mapped on chromosome 7 and of Arylsulphatase A (ARSA) and beta-galactosidase (GLB) as control lysosomal enzymes, whose loci are not assigned to number 7, in a group of 10 patients with myeloproliferative disorders associated with monosomy 7. A significant difference of the levels of activity of GUSB in monosomy 7 cells was found in comparison with two groups of controls, one of healthy subjects, the other of patients with similar disorders without monosomy 7. These results indicate the presence of a gene dosage effect for GUSB.",
author = "C. Danesino and F. Pasquali",
year = "1983",
language = "English",
volume = "7",
pages = "133--142",
journal = "Acta anthropogenetica",
issn = "0258-0357",
number = "2",

}

TY - JOUR

T1 - Gene dosage effect for beta-glucuronidase (GUSB) in monosomy 7 cells of patients with myeloproliferative disorders.

AU - Danesino, C.

AU - Pasquali, F.

PY - 1983

Y1 - 1983

N2 - The demonstration of a gene dosage effect in a neoplastic cell with a specific chromosome abnormality could be helpful in the study of some pathogenetic steps of the malignant growth. We tested the activities of beta-glucuronidase (GUSB), whose gene is mapped on chromosome 7 and of Arylsulphatase A (ARSA) and beta-galactosidase (GLB) as control lysosomal enzymes, whose loci are not assigned to number 7, in a group of 10 patients with myeloproliferative disorders associated with monosomy 7. A significant difference of the levels of activity of GUSB in monosomy 7 cells was found in comparison with two groups of controls, one of healthy subjects, the other of patients with similar disorders without monosomy 7. These results indicate the presence of a gene dosage effect for GUSB.

AB - The demonstration of a gene dosage effect in a neoplastic cell with a specific chromosome abnormality could be helpful in the study of some pathogenetic steps of the malignant growth. We tested the activities of beta-glucuronidase (GUSB), whose gene is mapped on chromosome 7 and of Arylsulphatase A (ARSA) and beta-galactosidase (GLB) as control lysosomal enzymes, whose loci are not assigned to number 7, in a group of 10 patients with myeloproliferative disorders associated with monosomy 7. A significant difference of the levels of activity of GUSB in monosomy 7 cells was found in comparison with two groups of controls, one of healthy subjects, the other of patients with similar disorders without monosomy 7. These results indicate the presence of a gene dosage effect for GUSB.

UR - http://www.scopus.com/inward/record.url?scp=0020924822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020924822&partnerID=8YFLogxK

M3 - Article

C2 - 6146321

AN - SCOPUS:0020924822

VL - 7

SP - 133

EP - 142

JO - Acta anthropogenetica

JF - Acta anthropogenetica

SN - 0258-0357

IS - 2

ER -